| Price | 79.00on 18-10-2019 at 16:30:00 |
|---|---|
| Change | -0.50 -0.63% |
| Buy | 80.00 |
| Sell | 78.00 |
| Buy / Sell AGL Shares | |
| Last Trade: | Buy 3,733 at 79.70p |
| Day's Volume: | 38,036 |
| Last Close: | 79.50p |
| Open: | 79.50p |
| ISIN: | GB0034330679 |
| Day's Range | 79.00p - 79.00p |
| 52wk Range: | 38.00p - 84.50p |
| Market Capitalisation: | £136m |
| VWAP: | 0.00p |
| Shares in Issue: | 173m |
Sector: Medicine and Biotech Research
Listed in: FTSE AIM All-Share
Recent Trades History ANGLE (AGL) |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 3,733 | 79.70 | Ordinary | 16:04:51 - 18-Oct-19 |
| Buy* | 12,569 | 79.56 | Ordinary | 14:42:44 - 18-Oct-19 |
| Sell* | 5,000 | 78.10 | Ordinary | 14:23:16 - 18-Oct-19 |
| Unknown* | 2,999 | 79.00 | Uncrossing Trade | 14:00:07 - 18-Oct-19 |
| Sell* | 5,000 | 78.25 | Ordinary | 13:53:01 - 18-Oct-19 |
| Buy* | 110 | 79.56 | Ordinary | 13:09:07 - 18-Oct-19 |
| Sell* | 5,000 | 79.10 | Ordinary | 10:52:39 - 18-Oct-19 |
| Sell* | 3,625 | 79.001 | Ordinary | 09:32:48 - 18-Oct-19 |
| Buy* | 35,000 | 80.00 | Ordinary Delayed publication | 16:30:57 - 17-Oct-19 |
| Buy* | 29,444 | 80.00 | Ordinary Delayed publication | 16:07:24 - 17-Oct-19 |
Share Price History for ANGLE |
|||||
| Date | Open | High | Low | Close | |
|---|---|---|---|---|---|
| 17th Oct 2019 (Thu) | 79.00 | 79.50 | 79.00 | 79.50 | |
| 16th Oct 2019 (Wed) | 79.00 | 80.00 | 79.00 | 79.00 | |
| 15th Oct 2019 (Tue) | 78.70 | 79.20 | 78.70 | 79.00 | |
| 14th Oct 2019 (Mon) | 78.20 | 80.00 | 79.60 | 78.70 | |
| 11th Oct 2019 (Fri) | 78.00 | 78.20 | 75.80 | 78.20 | |
| 10th Oct 2019 (Thu) | 78.00 | 78.00 | 78.00 | 78.00 | |
| 9th Oct 2019 (Wed) | 78.50 | 80.00 | 76.90 | 78.00 | |
| 8th Oct 2019 (Tue) | 77.50 | 78.50 | 75.00 | 78.50 | |
| 7th Oct 2019 (Mon) | 78.00 | 78.00 | 77.50 | 77.50 | |
| 4th Oct 2019 (Fri) | 78.50 | 79.50 | 78.00 | 78.00 | |
| 3rd Oct 2019 (Thu) | 81.50 | 81.50 | 77.50 | 77.50 | |
| 2nd Oct 2019 (Wed) | 83.00 | 83.00 | 81.30 | 81.50 | |
| 1st Oct 2019 (Tue) | 82.00 | 83.00 | 82.00 | 83.00 | |
| 30th Sep 2019 (Mon) | 82.00 | 82.00 | 82.00 | 82.00 | |
| 27th Sep 2019 (Fri) | 82.00 | 82.00 | 82.00 | 82.00 | |
| 26th Sep 2019 (Thu) | 82.00 | 82.00 | 81.50 | 81.50 | |
| 25th Sep 2019 (Wed) | 81.80 | 82.00 | 80.80 | 82.00 | |
| 24th Sep 2019 (Tue) | 82.00 | 82.00 | 81.80 | 81.80 | |
| 23rd Sep 2019 (Mon) | 82.50 | 83.00 | 82.00 | 82.00 | |
| 20th Sep 2019 (Fri) | 81.00 | 83.50 | 81.00 | 82.50 | |
News - Friday, September 13, 2019
Liquid biopsy company Angle said the University of Birmingham had published research indicating the potential of using CTC liquid biopsies to improve treatment of head and neck cancer and found that the company's liquid biopsy system held key advantages over other liquid biopsy systems. Key advantages of Angle's Parsortix system, over traditional tissue biopsies, included the ability to repeat the investigation at multiple time points and a reduction in overall healthcare costs, according to the research published by the University of Birmingham. 'Identified advantages of the Parsortix system, over other CTC liquid biopsy systems, are that it is not antibody-dependent and is able to detect all sub-populations of CTCs as well as CTC clusters,' the research noted. ...
